Product Information
LABETALOL HCL 100 MG/20 ML VL is a generic product labeled by Civica, Inc., priced at $0.1852 per ML under NDC 72572035001. Its NADAC has been published 107 times since Sep 18, 2024.
FDA first approved this application on May 28, 1999. Its Orange Book therapeutic-equivalence code is AP.
Strength
5 mg/mL
Manufacturer
Civica, Inc.NDC
72572035001
Classification
Generic
Dosage Form
INJECTION
Route
INTRAVENOUS
Effective Date
9/23/2026
Active Ingredients
LABETALOL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075303FDA Approved
5/28/1999
TE Code
AP
On Market Since
11/21/2019
Pharmacological Classes
Price Statistics
The NADAC for LABETALOL HCL 100 MG/20 ML VL has been published 107 times since Sep 18, 2024, and over the history we have for it it has declined 19.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1852 per ML |
|---|---|
| All-time high | $0.2354 (Jul 15, 2026) |
| All-time low | $0.1677 (May 21, 2025) |
| 52-week high | $0.2354 |
| 52-week low | $0.1677 |
| Median price | $0.1777 |
| Average price | $0.1881 |
| Largest weekly change | +40.4% (Apr 22, 2026) |
| Weeks tracked | 107 |
| Tracking since | Sep 18, 2024 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Civica, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Labetalol Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LABETALOL HCL 100 MG/20 ML VL?
The current National Average Drug Acquisition Cost (NADAC) for LABETALOL HCL 100 MG/20 ML VL, manufactured by Civica, Inc., is $0.1852 per ML (NDC 72572035001), effective Sep 30, 2026.
How has the price of LABETALOL HCL 100 MG/20 ML VL changed over time?
Over the history we have for it, the NADAC for LABETALOL HCL 100 MG/20 ML VL has declined 19.8%. It has been tracked across 107 weekly CMS publications since Sep 18, 2024.
What are the highest and lowest recorded NADAC prices for LABETALOL HCL 100 MG/20 ML VL?
Since Sep 18, 2024, the NADAC for LABETALOL HCL 100 MG/20 ML VL has ranged from a low of $0.1677 (May 21, 2025) to a high of $0.2354 (Jul 15, 2026), with a median of $0.1777 per ML.
Are there cheaper alternatives to LABETALOL HCL 100 MG/20 ML VL?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LABETALOL HCL 100 MG/20 ML VL in a comparable dosage form, but none are currently priced below it.
Who manufactures LABETALOL HCL 100 MG/20 ML VL?
LABETALOL HCL 100 MG/20 ML VL (NDC 72572035001) is labeled by Civica, Inc., and CMS classifies it as a generic product.